alpha-aminopyridine has been researched along with Colitis in 11 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (18.18) | 29.6817 |
| 2010's | 6 (54.55) | 24.3611 |
| 2020's | 3 (27.27) | 2.80 |
| Authors | Studies |
|---|---|
| Andoh, A; Araki, Y; Bamba, S; Bamba, T; Ban, H; Fujiyama, Y; Hattori, T; Kanauchi, O; Mukaisho, K; Sugihara, H | 1 |
| Alotaibi, NM; Murad, HA; Shaikh-Omar, A | 1 |
| Cho, HJ; Jeong, BS; Kim, ES; Kim, JA; Kim, SK; Lee, H; Lee, JS; Lee, YJ; Nam, TG | 1 |
| Abbas, H; Lim, Z; Malik, AA; Oo, ZM | 1 |
| Acharya, S; Chang, JH; Choi, DY; Jeong, BS; Jiang, L; Kim, JA; Lee, SY; Nam, TG; Neupane, S; Park, SW; Timilshina, M | 1 |
| Bundschuh, DS; Eigler, A; Endres, S; Lehr, HA; Rieder, F; Siegmund, B | 1 |
| Aksit, H; Ayvaz, S; Can, G; Can, H; Demirtas, S; Karaca, T; Korkmaz, U; Kurt, M; Yilmaz, B | 1 |
| Bhatia, DR; Bhatt, P; Bhonde, MR; Dadarkar, SD; Dagia, NM; Deore, V; Desai, NK; Gupte, RD; Jadhav, MG; Kumar, S; Sharma, S; Tannu, AA; Vishwakarma, RA; Yewalkar, N | 1 |
| Kühnel, D; Scholtka, B; Steinberg, P; Taugner, F | 1 |
| Diener, M; Steidle, J; Würner, L | 1 |
| Adamec, J; Baldridge, LA; Dudhgaonkar, S; Jedinak, A; Jiang, J; Lamb, JG; Loganathan, J; Sandusky, GE; Sliva, D; Terry, C | 1 |
1 review(s) available for alpha-aminopyridine and Colitis
| Article | Year |
|---|---|
CDK4/6 inhibitor-induced colitis: a case report and review of the literature.
Topics: Aged; Aminopyridines; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Colitis; Cyclin-Dependent Kinase 4; Cyclin-Dependent Kinase 6; Female; Humans; Letrozole; Purines; Receptor, ErbB-2; Receptors, Estrogen | 2021 |
10 other study(ies) available for alpha-aminopyridine and Colitis
| Article | Year |
|---|---|
Dextran sulfate sodium administered orally is depolymerized in the stomach and induces cell cycle arrest plus apoptosis in the colon in early mouse colitis.
Topics: Administration, Oral; Aminopyridines; Animals; Apoptosis; Caco-2 Cells; Cell Cycle Checkpoints; Cell Line, Tumor; Colitis; Colon; Dextran Sulfate; Disease Models, Animal; Humans; Inflammatory Bowel Diseases; Intestinal Mucosa; Male; Mice; Mice, Inbred BALB C | 2012 |
Rectal roflumilast improves trinitrobenzenesulfonic acid-induced chronic colitis in rats.
Topics: Aminopyridines; Animals; Benzamides; Colitis; Cyclopropanes; Disease Models, Animal; Mice; Peroxidase; Rats; Trinitrobenzenesulfonic Acid; Tumor Necrosis Factor-alpha | 2022 |
Antioxidant Analogue 6-Amino-2,4,5-Trimethylpyridin-3-ol Ameliorates Experimental Colitis in Mice.
Topics: Aminopyridines; Aniline Compounds; Animals; Antioxidants; Caco-2 Cells; Colitis; Cytokines; Disease Models, Animal; Humans; Intestinal Mucosa; Mice; Oxidative Stress; Permeability; Protective Agents; Severity of Illness Index; Treatment Outcome | 2021 |
Amelioration of Experimental autoimmune encephalomyelitis and DSS induced colitis by NTG-A-009 through the inhibition of Th1 and Th17 cells differentiation.
Topics: Aminopyridines; Animals; Cell Differentiation; Colitis; Encephalomyelitis, Autoimmune, Experimental; Mice; Signal Transduction; Th1 Cells; Th17 Cells | 2018 |
The selective phosphodiesterase 4 inhibitor roflumilast and phosphodiesterase 3/4 inhibitor pumafentrine reduce clinical score and TNF expression in experimental colitis in mice.
Topics: Aminopyridines; Animals; Antigens, CD; Antigens, Differentiation, T-Lymphocyte; Benzamides; Colitis; Colon; Cyclic Nucleotide Phosphodiesterases, Type 4; Cyclopropanes; Dextran Sulfate; Disease Models, Animal; Female; Interferon-gamma; Intestinal Mucosa; Lectins, C-Type; Mice; Naphthyridines; Phosphodiesterase 3 Inhibitors; Phosphodiesterase 4 Inhibitors; Spleen; Tumor Necrosis Factor-alpha | 2013 |
The Syk Inhibitor Fostamatinib Decreases the Severity of Colonic Mucosal Damage in a Rodent Model of Colitis.
Topics: Acetic Acid; Aminopyridines; Animals; Colitis; Disease Models, Animal; Intestinal Mucosa; Intracellular Signaling Peptides and Proteins; Male; Morpholines; Oxazines; Protein-Tyrosine Kinases; Pyridines; Pyrimidines; Rats; Rats, Sprague-Dawley; Syk Kinase | 2015 |
A novel mTOR inhibitor is efficacious in a murine model of colitis.
Topics: Aminopyridines; Anilides; Animals; Carrier Proteins; Cell Line, Tumor; Colitis; Dextran Sulfate; Disease Models, Animal; Humans; Interferon-gamma; Mice; Mice, Inbred BALB C; Mice, Inbred C57BL; Phosphotransferases (Alcohol Group Acceptor); TOR Serine-Threonine Kinases; Tumor Necrosis Factor-alpha | 2008 |
Inflammation does not precede or accompany the induction of preneoplastic lesions in the colon of 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine-fed rats.
Topics: Aminopyridines; Animals; Carcinogens; Colitis; Colon; Colonic Neoplasms; Hyperplasia; Imidazoles; Male; Precancerous Conditions; Rats; Rats, Inbred F344 | 2009 |
Altered response to hydrogen sulphide during experimental colitis in rats.
Topics: Aminopyridines; Analgesics; Animals; Colitis; Diet; Female; Hydrogen Sulfide; Inflammation; Intestines; Male; Rats; Rats, Wistar; Sulfur; Trinitrobenzenesulfonic Acid | 2013 |
Mushroom Ganoderma lucidum prevents colitis-associated carcinogenesis in mice.
Topics: Aminopyridines; Animals; Anti-Inflammatory Agents; Apoptosis; Carcinogens; Cell Proliferation; Cell Transformation, Neoplastic; Colitis; Colonic Neoplasms; Dextran Sulfate; Gastrointestinal Neoplasms; Gene Expression Regulation, Neoplastic; Humans; Hyperplasia; Imidazoles; Inflammation; Macrophages; Mice; Neoplasms, Experimental; Plant Extracts; Reishi | 2012 |